Skip to main content
SpringerLink
Log in
Book cover

Management of Rheumatic Disorders pp 357–378Cite as

General summary and conclusions, including new developments and future prospects

  • Chapter

  • 109 Accesses

Abstract

We are currently passing through a phase of rapid growth in the science and technology of medicine generally, and rheumatology in particular. The ‘established’ facts of yesterday’s practice have today become critically challenged and tomorrow will perhaps be replaced. One purpose of this chapter is to outline a few prominent areas of development in the treatment and management of rheumatic diseases and, where this is possible, to look into the future. Many of the topics discussed had barely reached medical attention when this book was started 3 years ago, some have arisen since, and doubtless more will be reported during the process of publication. Finally, an overall summary will be given.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Further Reading

Communication

  • Balint, E. and Norell, J.S. (eds) (1973) Six Minutes for the Patient: Interactions in General Practice Consultation, Tavistock, London.

    Google Scholar 

  • Harlem, O.K. (1977) Communication in Medicine. A Challenge to the Profession, Karger, Basle.

    Google Scholar 

  • McLachlan, G. (ed.) (1979) Mixed Communications, Published for the Nuffield Provincial Hospitals Trust by the Oxford University Press, Oxford.

    Google Scholar 

  • Moll, J.M.H. (1981) Studies of Visual Perception in Medical Communication, Ph.D. thesis, University of Leeds.

    Google Scholar 

  • Tanner, B. (ed.) (1976) Language and Communication in General Practice, H odder and Stoughton, London.

    Google Scholar 

Drugs New ways of administering established drugs Megadose corticosteroid therapy

  • Amos, R.S. (1982) Personal communication.

    Google Scholar 

  • Bolton, W.K. and Conser, W.G. (1979) Intravenous pulse methylprednisolone therapy of acute rapidly progressive glomerulonephritis. Am. J. Med., 66, 495.

    PubMed  CAS  Google Scholar 

  • Fessel, W.J. (1977) Reversal of azotaemia in lupus nephritis by megadose corticosteroid therapy. Arthr. Rheum. (Letter), 20, 1564.

    CAS  Google Scholar 

  • Fessel, W.J. (1980) Megadose corticosteroid therapy in systemic lupus erythematosus. J. Rheumatol, 7, 486.

    PubMed  CAS  Google Scholar 

  • Liebling, M.R., Lieb, E. McLaughlin et al. (1981) Pulse methylprednisolone in rheumatoid arthritis. Ann. Int. Med., 94, 21.

    PubMed  CAS  Google Scholar 

  • Mussché, M.M., Ringoir, S.M.G. and Lameire, N.N. (1976) High intravenous doses of methylprednisolone for acute cadaveric renal allograft rejection. Nephron, 16, 287.

    PubMed  Google Scholar 

Drugs Low-dose cyclophosphamide

  • Cooperating Clinics Committee of the American Rheumatism Association (1970) A controlled trial of cyclophosphamide in rheumatoid arthritis. N Engl. J. Med, 283, 883.

    Google Scholar 

  • Cooperating Clinics Committee of the American Rheumatism Association (1972) A controlled trial of high and low doses of cyclophosphamide in 82 patients with rheumatoid arthritis. Arthr. Rheum., 15, 434.

    Google Scholar 

  • Smyth, C.J., Bartholomew, B.A., Mills, D.M. et al. (1975) Cyclophosphamide therapy for rheumatoid arthritis. Arch. Int. Med., 135, 789.

    CAS  Google Scholar 

  • Williams, H.J., Reading, J.C., Ward, J.R. and O’Brien, W.M. (1980) Comparison of high and low dose cyclophosphamide therapy in rheumatoid arthritis. Arthr. Rheum., 23, 521.

    CAS  Google Scholar 

Drugs New disease applications of established drugs Colchicine

  • Allison, A.C. (1977) Effects of agents interacting with microtubules on collagen synthesis and breakdown. Ann. Rheum. Dis., 36 (Suppl.), 65.

    Google Scholar 

  • Harris, E.D. and Krane, S.M. (1971) Effects of colchicine on collagenase in cultures of rheumatoid synovium. Arthr. Rheum., 14, 669.

    CAS  Google Scholar 

  • Harris, E.D., Werb, Z., Cartwright, E. and Reynolds, J.J. (1975) Stimulation of collagenase release from synovial fibroblasts in monolayer culture by colchicine and related compounds. Scand. J. Rheumatol, 4 (Suppl. 8), 15.

    Google Scholar 

  • Hirsimaki, Y., Arstilla, A. and Trump, B.F. (1975) Auto-phagocytosis: in vitro induction by microtubule poisons. Exp. Cell Res., 92, 11.

    PubMed  CAS  Google Scholar 

  • Rojkind, M., Uribe, M. and Kershenobich, D. (1973) Colchicine in the treatment of liver cirrhosis. Lancet, i, 38.

    Google Scholar 

  • Schaerft, J.P. and Heersche, J.N.M. (1975) Accumulation of collagen-containing vacuoles in osteoblasts after administration of colchicine. Cell. Tiss. Res., 157, 353.

    Google Scholar 

Drugs Penicillamine

  • Bora, F.W., Lane, J.M. and Prockop, D.J. (1972) Inhibitors of collagen biosynthesis as a means of controlling scar formation in tendon injury. J. Bone Joint Surg., 54A, 1501.

    PubMed  CAS  Google Scholar 

  • Keiser, H.R. and Sjoerdsma, A. (1967) Studies on beta-amino proprionitrile in patients with scleroderma. Clin. Pharmacol. Ther., 8, 593.

    PubMed  CAS  Google Scholar 

  • Herbert, CM., Lindberg, K.A., Jayson, M.I.V. and Bailey, A.J. (1974) Biosynthesis and maturation of the skin collagen in scleroderma, and effect of D-penicillamine. Lancet, i, 187.

    Google Scholar 

  • Peacock, E.E. and Madden, J.W. (1969) Some studies on the effects of 1-amino proprionitrile in patients with injured flexor tendons. Surgery, 66, 215.

    PubMed  Google Scholar 

Drugs Gold

  • Dorwart, B., Gall, E.P., Schumacher, H.R. and Krauser, R.E. (1978) Chrysotherapy in psoriatic arthropathy. Arthr. Rheum., 21, 513.

    CAS  Google Scholar 

  • Editorial (1978) Treatment of arthritis associated with psoriasis. Br. Med. J., i, 262.

    Google Scholar 

  • Richter, M.B., Kinsella, P. and Corbett, M. (1980) Gold in psoriatic arthropathy. Ann. Rheum. Dis., 39, 279.

    PubMed  CAS  Google Scholar 

Drugs Dapsone

  • McConkey, B., Davis, P., Crockson, R.A. et al. (1976) Dapsone in rheumatoid arthritis. Rheumatol. Rehabil, 15, 230.

    PubMed  CAS  Google Scholar 

  • McConkey, B., Davis, P., Crockson, R.A. et al. (1979) Effects of gold, dapsone and prednisolone on serum C-reactive protein and haptoglobin and the ESR in rheumatoid arthritis. Ann. Rheum. Dis., 38, 141.

    PubMed  CAS  Google Scholar 

  • Swinson, D.R., Zlosnick, J. and Jackson, L. (1981) Double-blind trial of dapsone against placebo in the treatment of rheumatoid arthritis. Ann. Rheum. Dis., 40, 235.

    PubMed  CAS  Google Scholar 

Drugs Sulphasalazine

  • McConkey, B., Amos, R.S., Butler, E.P. et al. (1978) Salazo-pyrin in rheumatoid arthritis. Agents and Actions, 8, 438.

    PubMed  CAS  Google Scholar 

  • McConkey, B., Amos, R.S., Durham, S. et al. (1980) Sulphasalazine in rheumatoid arthritis. Br. Med. J., i, 442.

    Google Scholar 

Drugs Calcitonin

  • Bjelle, A.O. and Nilsson, B.E. (1971) The relationship between radiologic changes and osteoporosis of the hand in rheumatoid arthritis. Arthr. Rheum., 14, 646.

    CAS  Google Scholar 

  • Kennedy, A.C., Smith, D.A. Buchanan, W.W. et al. (1974) Osteoporosis in rheumatoid arthritis. Rev. Rheumatol, 4, 25.

    Google Scholar 

  • Lindsay, R. and Kennedy, A.C. (1976) in Bone Disease and Calcitonin, Symposium Proceedings (ed. J.A. Kanis), Armour, Eastbourne, p. 171.

    Google Scholar 

  • Mueller, M.N. and Jurist, J.M. (1973) Skeletal status in rheumatoid arthritis. Arthr. Rheum., 16, 66.

    CAS  Google Scholar 

Drugs Aspirin

  • Bentley, G., Leslie, I.J. and Fischer, D. (1981) Effect of aspirin treatment on chondromalacia patellae. Ann. Rheum. Dis., 40, 37.

    PubMed  CAS  Google Scholar 

  • Chrisman, O.D. and Snook, G.A. (1968) Studies on protective effect of aspirin against degeneration of human articular cartilage. Clin. Orthop., 56, 77.

    PubMed  CAS  Google Scholar 

  • Chrisman, O.D., Snook, G.A. and Wilson, T.C. (1972) The protective effect of aspirin against degeneration of human articular cartilage. Clin. Orthop., 84, 193.

    PubMed  CAS  Google Scholar 

  • Simmons, D.R. and Chrisman, O.D. (1965) Salicylate inhibition of cartilage degeneration. Arthr. Rheum., 8, 960.

    CAS  Google Scholar 

New and experimental drugs Tiaprofenic acid

  • Camp, V. (1981) Tiaprofenic acid in the treatment of rheumatoid arthritis. Rheumatol. Rehabil, 20, 181.

    PubMed  CAS  Google Scholar 

  • Wojtulewski, J., Walter, J. and Thornton, E.J. (1981) Tiaprofenic acid (Surgam) in the treatment of osteoarthritis of the knee and hip. Rheumatol. Rehabil, 20, 177.

    PubMed  CAS  Google Scholar 

Proquazones

  • Huskisson, E.C., Bryans, R. and Scott, J. (1981) Fluproquazone for osteoarthritis. Rheumatol. Rehabil, 20, 122.

    PubMed  CAS  Google Scholar 

  • Ruotsi, A. and Skifvard, B. (1981) Long-term double-blind comparative study on proquazone (Biarison) and ibuprofen in rheumatoid arthritis. Scand. J. Rheumatol, 21 (Suppl), 28.

    Google Scholar 

Isoxepac

  • Gerlis, L.S. and Gumpel, J.M. (1981) Isoxepac in rheumatoid arthritis: a double-blind comparison with aspirin. Rheumatol. Rehabil, 20, 50.

    PubMed  CAS  Google Scholar 

Orgotein

  • *Ahlengard, S., Tufvesson, G., Petterson, H. and Andersson, T. (1978) Treatment of traumatic arthritis in the horse with intra-articular orgotein (Palosein). Br. Equine Vet. J., 10, 122.

    CAS  Google Scholar 

  • Barra, D., Martini, F., Bossa, F. et al (1978) Primary structure of human copper-zinc superoxide dismutase. Cysteine and tryptophan-containing peptides. Biophys. Res. Commun., 81, 1195.

    CAS  Google Scholar 

  • Bors, W., Saran, M., Lengfelder, E. et al (1974) The relevance of the superoxide anion radical in biological systems. Curr. Top. Rad. Res. Q., 9, 247.

    CAS  Google Scholar 

  • *Breshears, D.E., Brown, CD., Riffel, D.M. et al. (1974) Evaluation of orgotein in treatment of locomotor dysfunction in dogs. Mod. Vet. Pract., 55, 85.

    PubMed  Google Scholar 

  • Carson, J., Vogin, E.E., Huber, W. and Schulte, T.L. (1973) Safety tests of orgotein, an anti-inflammatory protein. Toxicol. Appl. Pharmacol., 26, 184.

    PubMed  CAS  Google Scholar 

  • *Coffman, J.R., Johnson, J.H., Tritschler, L.G. et al. (1978) Orgotein in equine navicular disease: a double-blind study. J. Am. Vet. Med. Assoc., 174, 261.

    Google Scholar 

  • Cushing, L.S., Decker, W.E., Santos, F.K. et al. (1973) Orgotein therapy for inflammation in horses. Mod. Vet. Pract., 54, 17.

    PubMed  CAS  Google Scholar 

  • *Decker, W.E., Edmondson, A.H., Hill, H.E. et al. (1974) Local administration of orgotein in horses. Mod. Vet. Pract., 55, 773.

    PubMed  CAS  Google Scholar 

  • Fee, J. A. and Valentine, J.S. (1977) in Superoxide and Superoxide Dismutases (eds A.M. Michelson, J.M. McCord and I. Fridovich), Academic Press, London, pp. 19–60.

    Google Scholar 

  • Fridovich, I. (1974) Superoxide dismutase. Adv. Enzymol, 41, 35.

    PubMed  CAS  Google Scholar 

  • Fridovich, I. (1976) in Free Radicals in Biology (ed. W.A. Pryor), Vol. 1, Academic Press, New York, pp. 239–77.

    Google Scholar 

  • Geran, R.I. and Duros, J.D. (1975) Screening of orgotein for anti-tumour and chemotherapy-enhancing activity. Natl. Cancer Inst. Rep. N01-CM-33727.

    Google Scholar 

  • Huber, W. (1980) in Future Trends in Inflammation IV (eds D.A. Willoughby and J.P. Lancaster Giroud), MTP Press, Lancaster.

    Google Scholar 

  • Huber, W. and Menander-Huber, K.B. (1980) in Clinics in Rheumatic Diseases: Anti-Rheumatic Drugs II (ed. E.C. Huskisson), Vol. 6, No. 3, Saunders, London, p. 465.

    Google Scholar 

  • Huber, W. and Saifer, M.G.P. (1977) in Superoxide and Superoxide Dismutases (eds A.M. Michelson, J. McCord and I. Fridovich), Academic Press, London, pp. 517–36.

    Google Scholar 

  • Huber, W., Menander-Huber, K.B., Saifer, M.G.P. and Dang, P.H.-C. (1977) in Perspectives in Inflammation: Future Trend, and Developments (eds D.A. Willoughby, J.P. Giroud and G.P. Velo), MTP Press, Lancaster, pp. 527–40.

    Google Scholar 

  • Huber, W., Saifer, M.G.P. and Williams, L.D. (1980) in The Significance of Superoxide and Superoxide Dismutase. Vol. II — Biological and Clinical Aspects (eds W.H. Bannister and J.V. Bannister), Elsevier, New York.

    Google Scholar 

  • Huber, W., Schulte, T.L., Carson, S. et al. (1968) Some chemical and pharmacological properties of a novel antiinflammatory protein. Toxicol. Appl. Pharmacol., 12, 303.

    Google Scholar 

  • Ishioka, T. and Nishiie, K. (1979) Bioavailability of orgotein at various doses in twelve healthy Japanese males. Kiso To Riush, 13, 223.

    Google Scholar 

  • *Lund-Olesen, K. and Menander-Huber, K.B. (1974) Orgotein a new anti-inflammatory metalloprotein drug: preliminary evaluation of clinical efficacy and safety in degenerative joint disease. Curr. Ther. Res., 16, 706.

    PubMed  CAS  Google Scholar 

  • *Lund-Olesen, K. and Menander-Huber, K.B. (1977) Intraarticular orgotein therapy in osteoarthritis: a double-blind placebo-controlled trial. XIV International Congress of Rheumatology, San Francisco, June 26-July 1, 1977, Abstract 892.

    Google Scholar 

  • *Marberger, H., Menander-Huber, K.B., Huber, W. and Barsch, G. (1979) in Proceedings of Symposium. Active Oxygen and Medicine, Honolulu, January 30-February 2, 1979 (ed. A.P. Autor), Raven Press, New York.

    Google Scholar 

  • McGinness, J.E., Proctor, P.H., Demopoulos, H.B. et al. (1978) Amelioration of cis-platinum nephrotoxicity by orgotein (superoxide dismutase) Physiol. Chem. Phys., 10, 267.

    PubMed  CAS  Google Scholar 

  • *Schmidt, J.D. (1977) The evaluation of safety and efficacy of orgotein in urological disorders. Annual Meeting Western Section of the American Urological Association, San Francisco, Paper No. 25.

    Google Scholar 

  • Short, C.R. and Beadle, R.E. (1978) Superoxide dismutase — orgotein. Vet. Clin. N. Am., 8, 415.

    Google Scholar 

  • Williams, L.D., Saifer, M.G.P., Dang, P.C.-H. and Huber, W. (1980) in Future Trends in Inflammation IV (eds D.A. Willoughby and J.P. Giroud), MTP Press, Lancaster.

    Google Scholar 

  • Willson, R.L. (1979) in Oxygen Free Radicals and Tissue Damage. Ciba Foundation Symposium 65, New Series, Excerpta Medica, Amsterdam, pp. 19–42.

    Google Scholar 

Levamisole

  • Adams, J.G. (1978) Pharmacokinetics of levamisole, J. Rheumatol, 5 (Suppl. 4), 137.

    Google Scholar 

  • *Alcalay, M., Alcalay, D., Reboux, J.F. et al. (1977) Traitement de la polyarthrite rhumatoïde par le lévamisole. Résultats cliniques et immunologiques. Etude préliminaire, Nouv. Presse Méd., 6, 1959. Annotation (1975) Levamisole, Lancet, i, 151.

    PubMed  CAS  Google Scholar 

  • *Basch, C.M., Spitler, L.E. and Engleman, E.P. (1977) A double-blind cross-over trial of levamisole versus placebo in the therapy of patients with rheumatoid arthritis. Presented at the XlVth International Congress of Rheumatology, San Francisco, June26-July 1.

    Google Scholar 

  • *Boissy, M., Delcambre, B., Wattre, P. et al. (1978) Le traitement de la polyarthrite rhumatoïde par le levamisole (à propos de 13 cas personnels). Lille Méd., 23, 359.

    PubMed  CAS  Google Scholar 

  • *Catalan Pellet, A., Galvez, CA., Zelaya, R. and de Fonesca, M.L. (1977) Levamisol en artritis reumatoidea fundamento y fines de estudia. Rev. Med.-Quirurgica Asoc. Med. Hosp. Rivadavia, 20, 24.

    Google Scholar 

  • *D’Anglejan, G., Guedj, D., Debeyre, N. et al. (1977) Traitement de la polyarthrite rhumatoïde par le lévamisole chez 26 patients. Rev. Rhum., 44, 633.

    PubMed  Google Scholar 

  • *Danieli, G., Corvetta, A. and Persico, M. (1978) Levamisole nella malattia reumatoide. Presented at the IV Congresso delia Societa Italiana di Immunologia ed Immunopathologia, Bari, April21–23.

    Google Scholar 

  • *Davatchi, F., Chafizadeh, A., Massoud, A. and Jalili, M. (1977) Levamisole in the treatment of rheumatoid arthritis. Presented at the International Seminar on Treatment of Rheumatic Diseases, Petah-Tiqva, Israel, November27-December 3.

    Google Scholar 

  • *Delbarre, F. (1977) On the possible anti-rheumatic effects (immuno-effector?) of imidazole derivatives (levamisole, clotrimazole, niridazole). Biomedicine, 27, 97.

    PubMed  CAS  Google Scholar 

  • *Dinai, Y. and Pras, M. (1975) Levamisole in rheumatoid arthritis. Lancet, ii, 556

    Google Scholar 

  • *Di Perri, T., Auteri, A., Laghi Pasini, F. and Mattioli, F. (1978) A weekly oral dose of levamisole in the treatment of rheumatoid arthritis associated with E-rosette lymphocyte reduction. Eur. J. Rheumatol. Inflam., 1, 155.

    Google Scholar 

  • *El-Ghobarey, A.F., Mavrikakis, M.E., Macleod, M. et al. (1978) Clinical and laboratory studies of levamisole in patients with rheumatoid arthritis. Q. J. Med. New Ser., 47, 385.

    CAS  Google Scholar 

  • Empire Rheumatism Council (1960) Gold therapy in rheumatoid arthritis. Ann. Rheum. Dis., 19, 95.

    Google Scholar 

  • Empire Rheumatism Council (1961) Relation of toxic reactions in gold therapy to improvement in rheumatoid arthritis. Ann. Rheum. Dis., 20, 335.

    Google Scholar 

  • *Gallice, R. (1977) Emploi du levamisole dans les rhumatismes inflammatoires, Thesis, Marseille.

    Google Scholar 

  • Goldstein, G. (1978) Mode of action of levamisole. J. Rheumatol, 5 (Suppl. 4), 143.

    Google Scholar 

  • Grahame, R., Billings, R., Laurence, M. et al. (1974) Tissue gold levels after chrysotherapy. Ann. Rheum. Dis., 33, 536.

    PubMed  CAS  Google Scholar 

  • *Guaydier, G., Loyau, J.-F. G., Dumas, M. et al. (1977) Traitement de la polyarthrite rhumatoide par le levamisole. Premiers resultats. Nouv. Presse Méd., 6, 3332.

    PubMed  CAS  Google Scholar 

  • *Huskisson, E.C. (1978) The place of levamisole in the armamentarium for rheumatoid arthritis. J. Rheumatol., 5 (Suppl. 4), 149.

    Google Scholar 

  • *Huskisson, E.C., Dieppe, P.A., Scott, J. et al. (1976) Immuno-stimulant therapy with levamisole for rheumatoid arthritis, Lancet, i, 393.

    Google Scholar 

  • Janssen, P.A.J. (1976) The levamisole story. Progr. Res., 20, 347.

    CAS  Google Scholar 

  • *Kalfa, G. (1978) Traitement de la polyarthrite rhumatoide par le lévamisole à propos de observationsn, Thesis, Montpellier.

    Google Scholar 

  • *Leca, A.P., Crouzet, J., Prier, A. and Camus, J.-P. (1976) Vingt cas de polyarthrite rheumatoide traités par le lévamisole, Nouv. Presse Méd., 5, 89.

    PubMed  CAS  Google Scholar 

  • Lequesne, M. and Floquet, J. (1976) Les effets secondaires au cours des traitements prolonges par le levamisole notamment dans les polyarthrites. Nouv. Presse Méd., 5, 358.

    Google Scholar 

  • *Levy, J. (1978) Levamisole and cellular immunity in rheumatoid arthritis — clinical and laboratory correlates. J. Rheumatol., 5 (Suppl. 4), 63.

    Google Scholar 

  • *Lewi, P.J. and Symoens, J. (1978) Levamisole in rheumatoid arthritis — a multivariate analysis of a multicentre study. J. Rheumatol., 5 (Suppl. 4), 17.

    Google Scholar 

  • Lorber, A., Atkins, C.J., Chang, C.C. et al. (1973) Monitoring serum gold levels to improve chrysotherapy in rheumatoid arthritis. Ann. Rheum. Dis., 32, 133.

    PubMed  CAS  Google Scholar 

  • *Meyers, A.R. and Schimmer, B.M. (1977) Levamisole in rheumatoid arthritis. Presented at the International Seminar on Treatment of Rheumatic Diseases, Petah-Tiqva, Israel, November27-December 3.

    Google Scholar 

  • *Michel, A.P.M. (1978) Essai thérapeutique par le lévamisole dans la polyarthrite rheumatoide. Thesis, Strasbourg.

    Google Scholar 

  • Mielants, H. and Veys, E.M. (1978) A study of the hematological side-effects of levamisole in rheumatoid arthritis, with recommendations. J. Rheumatol., 5 (Suppl. 4), 77.

    Google Scholar 

  • *Miller, B., Srinivasan, R., Fan, P. et al. (1977) Clinical and immunological effects of levamisole in rheumatoid arthritis (RA) patients. A double-blind placebo-controlled cross-over study. Presented at the XIVth International Congress of Rheumatology, San Francisco, June26-July 1.

    Google Scholar 

  • Mowat, A.G. (1978) Levamisole and cellular immunity in rheumatoid arthritis — a review. J. Rheumatol., 5 (Suppl. 4), 55.

    Google Scholar 

  • *Multicentre Study Group (1978a) Levamisole in rheumatoid arthritis. A randomized double-blind study comparing two dosage regimens of levamisole with placebo. Lancet, ii, 1007.

    Google Scholar 

  • *Multicentre Study Group (1978b) A multicentre randomized double-blind study comparing two dosages of levamisole in rheumatoid arthritis. J. Rheumatol., 5 (Suppl. 4), 5.

    Google Scholar 

  • Multicentre Study Group (1982) Levamisole in rheumatoid arthritis. Final report on a randomized double-blind study comparing a single weekly dose of levamisole with placebo. Ann. Rheum. Dis., 41, 159.

    Google Scholar 

  • Pinals, R.S. (1978) The non-hematological side-effects of levamisole in the treatment of rheumatoid arthritis — a review. J. Rheumatol., 5 (Suppl. 4), 71.

    Google Scholar 

  • Renoux, G. and Renoux, M. (1977) Mécanismes d’action du levamisole, stimulant des responses d’immunité cellulaire. Ann. Immunol. (Inst. Pasteur), 128C, 275.

    CAS  Google Scholar 

  • *Roig Escofet, D., Valverde Garcia, J., Arnal Guimera, C. et al. (1977) El levamisole en el tratamiento de la arthritis re-umatoidea. Rev. Esp. Reum., 4, 23.

    Google Scholar 

  • Rosenthal, M. (1978) A critical review of the effect of levamisole in rheumatic diseases other than rheumatoid arthritis. J. Rheumatol, 5 (Suppl. 4), 97.

    Google Scholar 

  • Rosenthal, M., Trabert, U. and Müller, W. (1976) Immunotherapy with levamisole in rheumatic diseases. Scand. J. Rheumatol, 5, 216.

    PubMed  CAS  Google Scholar 

  • *Runge, L.A., Pinnais, R.S., Lourie, S.H. and Tomar, R.H. (1977) Treatment of rheumatoid arthritis with levamisole: a controlled trial. Arthr. Rheum., 20, 1445.

    CAS  Google Scholar 

  • Sagawa, K., Nakazawa, T., Ishiguro, Y. et al. (1977) Immu-nomodulating drugs (levamisole and D-penicillamine) and cellular immunity. Presented at the XlVth International Congress of Rheumatology, San Francisco, June26-July 1.

    Google Scholar 

  • Sany, J. (1978) A review of the effects of levamisole on erythrocyte sedimentation rate, acute phase proteins, and anaemia. J. Rheumatol, 5 (Suppl. 4), 43.

    Google Scholar 

  • Schuermans, Y. (1975) Levamisole in rheumatoid arthritis. Lancet, i, 111.

    Google Scholar 

  • *Scott, J., Dieppe, P.A. and Huskisson, E.C. (1978) Continuous and intermittent levamisole. A controlled trial. Ann. Rheum. Dis., 37, 259.

    PubMed  CAS  Google Scholar 

  • Silverg, D.A., Kidd, E.G., Shnitka, T.K. and Ulan, R.A. (1970) Gold nephropathy. Arthr. Rheum., 13, 812.

    Google Scholar 

  • Symoens, J. and Lewi, P.J. (1978) Degree of responsiveness to levamisole and factors influencing responsiveness and adverse reactions. J. Rheumatol, 5 (Suppl. 4), 26.

    Google Scholar 

  • Symoens, J. and Rosenthal, M. (1977) Levamisole in the modulation of the immune response: the current experimental and clinical state. J. Reticuloendothel. Soc., 21, 175.

    PubMed  CAS  Google Scholar 

  • Symoens, J. and Schuermans, Y. (1979) in Clinics in the Rheumatic Diseases. Anti-Rheumatic Drugs, (ed. E.C. Huskisson), Vol. 5, No. 2, Saunders, London, p. 603.

    Google Scholar 

  • Symoens, J., de Cree, J., Van Bever, W. and Janssen, P.A.J. (1979) in Pharmacological and Biochemical Properties of Drug Substances (ed. M.E. Goldberg), Vol. 2, American Pharmaceutical Association, p. 407.

    Google Scholar 

  • Symoens, J., Veys, E., Mielants, H. and Pinals, R. (1979b) Adverse reactions to levamisole. Cancer Treat. Rep., 62, 1721.

    Google Scholar 

  • Veys, E.M., Mielants, H., De Bussere, A. et al (1976) Levamisole in rheumatoid arthritis. Lancet, i, 808.

    Google Scholar 

  • Willoughby, D.A. and Wood, C. (eds) (1977) in Forum on Immunotherapy, Royal Society of Medicine, London, p. 3.

    Google Scholar 

  • Wilton, J.M.A. (1978) Levamisole in chronic inflammatory diseases. J. Rheumatol, 5 (Suppl. 4), 101.

    Google Scholar 

  • Yaron, M., Yaron, L. and Herzberg, M. (1976) Levamisole in rheumatoid arthritis. Lancet, i, 369.

    Google Scholar 

Zinc

  • Job, C., Menkes, C.J. and Delbarre, F. (1980) Zinc sulphate in the treatment of rheumatoid arthritis, Arthr. Rheum., 23, 1409.

    Google Scholar 

  • Menkes, C.J., Job, C. and Delbarre, F. (1978) Traitement de la polyarthrite rhumatoïde par le sulfate de zinc per os, Nouv. Presse Méd., 7, 760.

    PubMed  CAS  Google Scholar 

  • Sunkin, P.A. (1976) Oral zinc sulphate in rheumatoid arthritis. Lancet, ii, 539.

    Google Scholar 

Oral Gold

  • *Berglöf, F.-E., Berglöf, K. and Walz, D.T. (1978) Auranofin: an oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. J. Rheumatol, 5, 68.

    PubMed  Google Scholar 

  • *Champion, G.D. (1979) Auranofin, an oral gold compound for the treatment of rheumatoid arthritis. Austr. N. Z. J. Med., 3, 348.

    Google Scholar 

  • *Di Martino, M.J. and Walz, D.T. (1977) Inhibition of lysomal enzyme release from rat leukocytes by auranofin: a new chrysotherapeutic agent. Inflammation, 2, 131.

    Google Scholar 

  • Finkelstein, A.E., Roisman, F.R., Batista, V. et al (1980) Oral chrysotherapy in rheumatoid arthritis: minimum effective dose. J. Rheumatol, 7, 160.

    PubMed  CAS  Google Scholar 

  • *Finkelstein, A.E., Walz, D.T., Batista, V. et al (1976) Auranofin. New oral gold compound for treatment of rheumatoid arthritis. Ann. Rheum. Dis., 35, 251.

    PubMed  CAS  Google Scholar 

  • *Gottlieb, N.L. (1979a) Gold excretion and retention during auranofin treatment: a preliminary report. J. Rheumatol, 6 (Suppl. 5), 61.

    Google Scholar 

  • *Gottlieb, N.L. (1979b) Gold excretion and retention during oral gold (auranofin) therapy. Arthr. Rheum., 22, 615.

    Google Scholar 

  • *Gottlieb, N.L., Riskin, W., Maken, C. et al. (1980) Extended experience with auranofin in rheumatoid arthritis. Arthr. Rheum., 23, 684.

    Google Scholar 

  • *Hill, D.T. and Sutton, B.M. (1980) Oral gold: auranofin, a novel antiarthritic agent, its Mossbauer spectrum and X-ray crystal structure determination. Abstract from 179th ACS National Meeting, Texas, March 23–28, Medicine and Chemistry Section, Abstract 16.

    Google Scholar 

  • *Meyers, O.L. (1979) Experience with an oral gold formulation for the treatment of rheumatoid arthritis. IX European Congress of Rheumatology, Wiesbaden, September 2–8, p. 161, Abstract 723.

    Google Scholar 

  • *Payne, B.J. and Arena, E. (1978a) The subacute and chronic toxicity of SK & F 36914 and SK & F D-39162 in dogs. Vet. Pathol, 15 (Suppl. 5), 9.

    PubMed  CAS  Google Scholar 

  • *Payne, B.J. and Arena, E. (1978b) The subacute and chronic toxicity of SK & F 36914, SK & F D-39162 and gold sodium thiomalate in rats. Vet. Pathol., 15 (Suppl. 5), 13.

    PubMed  CAS  Google Scholar 

  • *Roth, S. (1980) Preliminary long-term multidosage evaluation of auranofin in rheumatoid arthritis. Abstract from 4th Congress of Southeast Asia and Pacific Area League against Rheumatism, Manila, January, p. 34, Abstract 97.

    Google Scholar 

  • *Sutton, B.M., McGuity, E., Walz, D.T. and Di Martino, M.J. (1972) Oral gold: anti-arthritic properties of alkyl phosphine gold-ordination complexes. J. Med. Chem., 15, 1095.

    PubMed  CAS  Google Scholar 

  • *Walz, D.T. and Griswold, D.E. (1978) Immunopharmacology of gold sodium thiomalate and auranofin (SK & F D-39162): effects on cell-mediated immunity. Inflammation, 3, 117.

    PubMed  CAS  Google Scholar 

  • *Weisman, M.H. and Hannifin, D.M. (1979) Management of rheumatoid arthritis with oral gold. Arthr. Rheum., 22, 922.

    CAS  Google Scholar 

Potential for new drugs Drugs for treating osteoarthrosis

  • Byers, P.D. (1974) The effect of high femoral osteotomy on osteoarthritis of the hip. J. Bone Joint Surg., 56B, 279.

    CAS  Google Scholar 

  • Campbell, C.J. (1969) The healing of cartilage defects. Clin. Orthop., 64, 45.

    PubMed  CAS  Google Scholar 

  • Chrisman, O.D., Snook, G.A. and Wilson, T.C. (1972) The protective effect of aspirin against degeneration of human articular cartilage. Clin. Orthop., 84, 193.

    PubMed  CAS  Google Scholar 

  • Dingle, J.T. (1979) Herberden Oration, 1978. Recent studies on the control of joint damage: the contribution of the Strangeways Research Laboratory. Ann. Rheum. Dis., 38, 201.

    PubMed  CAS  Google Scholar 

  • Dingle, J.T., Gordon, J.L., Hazleman, B.L. et al (1978) Joint inflammation: a novel treatment. Nature, 271, 372.

    PubMed  CAS  Google Scholar 

  • Meachim, G. and Roy, S. (1969) Surface ultrastructure of mature adult human articular cartilage. J. Bone Joint Surg., 51B, 529.

    CAS  Google Scholar 

  • Perry, G.H., Smith, M.J.G. and Whiteside, C.G. (1972) Spontaneous recovery of the joint space in degenerative hip disease. Ann. Rheum. Dis., 31, 440.

    PubMed  CAS  Google Scholar 

  • Riddle, W.E. (1970) Healing of articular cartilage in the horse. J. Am. Vet. Med. Assoc, 157, 1471.

    PubMed  Google Scholar 

  • Sokoloff, L. (1979) in The Aetiopathogenesis of Osteoarthrosis (ed. G. Naki), Pitman, Tunbridge Wells, p. 1.

    Google Scholar 

Drugs for treating ankylosing spondylitis

  • Flora, L. (1979) Comparative anti-inflammatory and bone protective effects of two diphosphonates in adjuvant arthritis. Arthr. Rheum., 22, 340.

    CAS  Google Scholar 

  • Francis, M.D., Flora, L. and King, W.R. (1972) The effects of disodium ethane-1-hydroxy-1, 1-diphosphonate on adjuvant arthritis in rats. Cal Tiss. Res., 9, 109.

    CAS  Google Scholar 

  • Russell, R.G.G. and Fleisch, H. (1976) in The Biochemistry and Physiology of Bone (ed. G. Bourne), Vol. IV, Academic Press, New York.

    Google Scholar 

  • Russell, R.G.G. (1980) in Ankylosing Spondylitis (ed. J.M.H. Moll), Churchill Livingstone, Edinburgh, p. 285.

    Google Scholar 

Plasma exchange, leucopheresis, and thoracic duct drainage

  • Lockwood, C.M., Pearson, T.A., Rees, A.J. et al. (1976) Immunosuppression and plasma-exchange in the treatment of Goodpasture’s syndrome. Lancet, i, 711.

    Google Scholar 

  • Lockwood, C.M., Worrledge, S., Nicholas, A. et al. (1979) Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. TV. Engl. J. Med, 300, 524.

    CAS  Google Scholar 

  • Moran, C.J., Parry, H.F., Mowbray, J. et al. (1977) Plasmaphoresis in systemic lupus erythematosus. Br. Med. J., i, 1573.

    Google Scholar 

  • Parry, H.F., Moran, C.J., Snaith, M.L. et al. (1981) Plasma exchange in systemic lupus erythematosus. Ann. Rheum. Dis., 40, 224.

    PubMed  CAS  Google Scholar 

  • Pearson, C.M., Paulus, H.E. and Machleder, H.I. (1975) The role of the lymphocyte and its products in the propagation of joint disease. Ann. N. Y. Acad. Sci., 256, 150.

    PubMed  CAS  Google Scholar 

  • Pinching, A.J., Peters, D.K. and Newsom Davis, J. (1976) Remission of myasthenia gravis following plasma-exchange. Lancet, ii, 1373.

    Google Scholar 

  • Rothwell, R.S., Davis, P., Gordon, P.A. et al (1980) A controlled study of plasma exchange in the treatment of severe rheumatoid arthritis. Arthr. Rheum., 23, 785.

    CAS  Google Scholar 

  • Schlansky, R., Dehoratius, R.J., Pincus, T. and Timoy, K.S.K. (1981) Plasmapheresis in systemic lupus erythematosus. Arthr. Rheum., 24, 49.

    CAS  Google Scholar 

  • Tenenbaum, J., Urowitz, M.B., Keystone, E.C. et al. (1979) Leucopheresis in severe rheumatoid arthritis. Ann. Rheum. Dis., 38, 40.

    PubMed  CAS  Google Scholar 

  • Verrier-Jones, J., Bucknall, R.C., Cumming, R.H. et al. (1976) Plasmapheresis in the management of acute systemic lupus erythematosus. Lancet, i, 709.

    Google Scholar 

  • Wallace, D.J., Goldfinger, D., Gatti, R. et al. (1979) Plasmapheresis and lymphoplasmapheresis in the management of rheumatoid arthritis. Arthr. Rheum., 22, 703.

    CAS  Google Scholar 

Intra-articular injection agents Osmic acid

  • Anttinen, J. and Oka, A. (1975) Intra-articular triamcinolone hexacetonide and osmic acid in persistent synovitis of the knee. Scand. J. Rheumatol., 4, 125.

    PubMed  CAS  Google Scholar 

  • Berglof, F.E. (1959) Osmic acid in arthritis therapy. Acta Rheumatol. Scand., 5, 70.

    PubMed  CAS  Google Scholar 

  • Hurri, L., Sievers, K. and Oka, M. (1963) Intra-articular osmic acid in rheumatoid arthritis. Acta Rheumatol. Scand., 9, 20.

    PubMed  CAS  Google Scholar 

  • Martio, J., Isomaki, H., Heikkola, T. and Laine, V. (1972) The effects of intra-articular osmic acid in juvenile rheumatoid arthritis. Scand. J. Rheumatol., 1, 5.

    PubMed  CAS  Google Scholar 

  • Menkes, C.J. (1979) Is there a place for chemical and radiation synovectomy in rheumatic diseases? Rheumatol. Rehabil, 18, 65.

    PubMed  CAS  Google Scholar 

  • Nissila, M., Isomaki, H., Kosta, K. et al. (1977) Osmic acid in rheumatoid synovitis: a controlled study. Scand. J. Rheumatol., 6, 111.

    PubMed  CAS  Google Scholar 

  • Sheppeard, H. and Ward, D.J. (1980) Intra-articular osmic acid in rheumatoid arthritis: five years’ experience. Rheumatol. Rehabil., 19, 25.

    PubMed  CAS  Google Scholar 

  • Von Reis, G. and Swensson, A. (1951) Intra-articular injections of osmic acid in painful joint affections. Acta Med. Scand, 259 (Suppl. 140), 27.

    Google Scholar 

Methotrexate

  • Hall, G.H. and Head, A.C. (1975) Intra-articular methotrexate. Lancet, ii, 409.

    Google Scholar 

  • Hall, G.H., Jones, B.J.M., Head, A.C. and Jones, V.E. (1978) Intra-articular methotrexate. Clinical and laboratory study in rheumatoid and psoriatic arthritis. Ann. Rheum. Dis., 37, 351.

    PubMed  CAS  Google Scholar 

  • Marks, J.S., Stewart, I.M. and Hunter, J.A.A. (1976) Intraarticular methotrexate in rheumatoid arthritis. Lancet, ii, 857.

    Google Scholar 

Effect of increasing volume of intra-articular hydrocortisone

  • Corbett, M., Seifert, M.H., Hacking, B. and Webb, S. (1970) Comparison between local injections of silicone and hydrocortisone acetate in chronic arthritis. Br. Med. J., i, 24.

    Google Scholar 

  • Sheldon, P. and Beer, T.C. (1973) Synovitis of the knee treated by intra-articular hydrocortisone acetate, hydrocortisone acetate plus saline or saline alone. Rheumatol. Rehabil, 12, 37.

    PubMed  CAS  Google Scholar 

Chemonucleolysis

  • Graham, C.E. (1976) Chemonucleolysis: a double blind study comparing chemonucleolysis with intra-discal hydrocortisone in the treatment of backache and sciatica. Clin. Orthop., 117, 184.

    Google Scholar 

  • Graham, C.E. (1980) in Clinics in Rheumatic Diseases (ed. R. Grahame), Vol. 6, No. 1. Saunders, London, p. 179.

    Google Scholar 

  • Macnab, I., McCulloch, J.A., Weiner, D.S. et al. (1971) Chemonucleolysis. Can. J. Surg., 14, 280.

    PubMed  CAS  Google Scholar 

  • Smith, L. and Brown, J.E. (1967) Treatment of lumbar intervertebral disc lesions by direct injection of chymopapain. J. Bone Joint Surg., 49B, 502.

    CAS  Google Scholar 

Surgery

  • Evarts, C.M. (1980) in Topical Reviews in Rheumatic Disorders (ed. A.G.S. Hill), Vol. 1, Wright, Bristol, p. 375.

    Google Scholar 

  • Hill, A.G.S. (1980) in Topical Reviews in Rheumatic Disorders (ed. A.G.S. Hill), Vol. 1, Wright, Bristol, p. 62.

    Google Scholar 

  • Laurence, M. (1975) Growth areas in the surgical treatment of rheumatoid arthritis. Rheumatol. Rehabil., 14, 203.

    PubMed  CAS  Google Scholar 

  • Morris, J.R.W. (1978) in Surgical Management of Rheumatoid Arthritis. Clinics in Rheumatic Diseases (ed. A.G. Mowat), Vol. 4, Saunders, London, p. 469.

    Google Scholar 

  • Wright, V. and Seedhom, B.B. (1980) in Topical Reviews in Rheumatic Diseases, (ed. A.G.S. Hill), Vol. 1, Wright, Bristol, p. 64.

    Google Scholar 

Rehabilitation

  • Chamberlain, M.A., Thornley, G., Stowe, J. and Wright, V. (1981) Evaluation of aids and equipment for the bath: II. A possible solution to the problem. Rheumatol. Rehabil., 20, 38.

    PubMed  CAS  Google Scholar 

  • Cochrane, G. and Glanville, H. (1977) in Rehabilitation Today (ed. S. Mattingley), Update, London, p. 59.

    Google Scholar 

  • Ekblom, B., Lovgren, O., Alderin, M. et al. (1975) Effect of short-term physical training on patients with rheumatoid arthritis. Scand. J. Rheumatol., 4, 80.

    PubMed  CAS  Google Scholar 

  • Dixon, A. St. J. (1973) Progress and problems in back pain research. Rheumatol. Rehabil., 12, 165.

    Google Scholar 

  • Garrett, T.K. (1976) BXL Plastazote: a useful aid in both treatment and rehabilitation. Rheumatol. Rehabil., 15, 283.

    PubMed  CAS  Google Scholar 

  • Glover, J.R. (1971) Occupational health research and the problem of back pain. Trans. Soc. Occupatl. Med., 21, 2.

    CAS  Google Scholar 

  • Gumpel, J.M. and Cannon, S. (1981) A cross-over comparison of ready-made fabric wrist-splints in rheumatoid arthritis. Rheumatol. Rehabil., 20, 113.

    PubMed  CAS  Google Scholar 

  • Machover, S. and Sapecky, A.J. (1966) Effect of isometric exercise on the quadriceps muscle in patients with rheumatoid arthritis. Arch. Phys. Med. Rehabil, 47, 737.

    PubMed  CAS  Google Scholar 

  • Mathews, J.A. and Hickling, J. (1975) Lumbar traction: a double-blind controlled study for sciatica. Rheumatol. Rehabil, 14, 222.

    PubMed  CAS  Google Scholar 

  • Pearce, J. and Moll, J.M.H. (1967) Conservative treatment and natural history of acute lumbar disc lesions. J. Neurol. Neurosurg. Psychiatr., 30, 13.

    Google Scholar 

  • Robinson, H.S., Haldeman, J., Imrie, J. and Neubauer, P. (1980) Evaluation of a province-wide physiotherapy monitoring service in an arthritis control programme. J. Rheumatol, 7, 387.

    PubMed  CAS  Google Scholar 

  • Vignos, P.J. (1980) Editorial: physiotherapy in rheumatoid arthritis. J. Rheumatol, 7, 269.

    PubMed  Google Scholar 

Heterodox procedures

  • Editors of Consumer Reports Books (1980) Health quackery, Consumers Union’s Report on False Health Claims, Worthless Remedies and Unproved Therapies, Consumers Union, New York.

    Google Scholar 

  • Gibson, R.G., Gibson, S.L.M., Conway, V. and Chappell, D. (1980) Perna canaliculus in the treatment of arthritis. Practitioner, 224, 955.

    PubMed  CAS  Google Scholar 

  • Huskisson, E.C., Scott, J. and Bryans, R. (1981) Seatone is ineffective in rheumatoid arthritis. Br. Med. J., 283, 1358.

    Google Scholar 

  • Miller, T.E. and Ormrod, D. (1980) The anti-inflammatory activity of Perna canaliculus (NZ green-lipped mussel). N. Z. Med. J., 92, 187.

    PubMed  CAS  Google Scholar 

Experimental models

  • Blackham, A. and Radziwonik, H. (1977) The effect of drugs in established rabbit monoarticular arthritis. Agents and Actions, 7, 473.

    PubMed  CAS  Google Scholar 

  • Floman, Y., Okon, E. and Zor, U. (1977) Role of prostaglandins on experimental arthritis in rat. Clin. Orthop., 125, 214.

    PubMed  Google Scholar 

  • Gerber, N.L., Powell, D. and Steinberg, A.D. (1977) Therapeutic studies in NZB/NZWF, mice. V. Comparison of cyclophosphamide and chlorambucil. Arthr. Rheum., 20, 1263.

    CAS  Google Scholar 

  • Hannan, P.C.T. (1977) Sodium aurothiomalate, gold kera-tinate, and various tetracyclines in mycoplasma-induced arthritis of rodents. J. Med. Microbiol., 10, 87.

    PubMed  CAS  Google Scholar 

  • MacKenzie, A.R., Pick, C.B., Sibley, P.R. and White, B.P. (1978) Suppression of rat adjuvant disease by cyclophosphamide pretreatment: evidence for an antibody mediated component in the pathogenesis of the disease. Clin. Exp. Immunol, 32, 86.

    PubMed  CAS  Google Scholar 

  • Rheumatism Review Subcomittee of the American Rheumatism Association (1981) Experimental models. In Twenty-fourth Rheumatism Review. Arthr. Rheum., 24,315.

    Google Scholar 

  • Russell, R.G.G. (1980) in Ankylosing Spondylitis, (ed. J.M.H. Moll) Churchill Livingstone, Edinburgh, pp. 291–2.

    Google Scholar 

  • Steinberg, A.D., Krakaner, R., Reinertsen, J.L. et al. (1978) Therapeutic studies in NZB/NZW mice. VI. Age-dependent effects on concanavalin A stimulated spleen cell supernate. Arthr. Rheum., 21, 204.

    CAS  Google Scholar 

  • Wigley, R.D. (1977) Models of rheumatic disease occurring spontaneously in mice. Sem. Arthr. Rheum., 7, 81.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology, Nether Edge Hospital, Sheffield, UK

    J. M. H. Moll BSc, DM, PhD, FRCP (Consultant Physician, Head, Honorary Clinical Lecturer)

  2. Sheffield Centre for Rheumatic Diseases, UK

    J. M. H. Moll BSc, DM, PhD, FRCP (Consultant Physician, Head, Honorary Clinical Lecturer)

  3. Rheumatic Diseases, University of Sheffield, UK

    J. M. H. Moll BSc, DM, PhD, FRCP (Consultant Physician, Head, Honorary Clinical Lecturer)

Authors
  1. J. M. H. Moll BSc, DM, PhD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1983 J. M. H. Moll

About this chapter

Cite this chapter

Moll, J.M.H. (1983). General summary and conclusions, including new developments and future prospects. In: Management of Rheumatic Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3140-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-3140-5_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-412-15790-5

  • Online ISBN: 978-1-4899-3140-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation